The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
800+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
393+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
New
Shop neurotech products
EEG headsets, sleep wearables and brain stimulation devices you can buy today.
Browse by category
View all 800 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
Funding spotlight
Axon Intelligence
Seed — $8M
MindBridge Neuro
Series B — $45M
Neurode Therapeutics
Series A — $22M
iMediSync
Series B
Myomo
Publicly traded (NYSE American: MYO)
Nexalin Technology
Publicly traded (NASDAQ: NXLI)
Latest news
People living with ALS will now have direct input into BCI development decisions, marking a shift toward patient-centered neurotech design.
Science Corporation has raised $400M to commercialize its BCI device, marking one of the largest single funding rounds in neurotechnology history.
Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.
The impossibility of blinding BCI clinical trials poses fundamental methodological challenges that could reshape how the field validates its devices.
New clinical trial data shows implanted brain-computer interfaces successfully restoring expressive communication in paralyzed patients.
Synchron has suspended its brain-computer interface clinical trials after the implanted device failed to perform as expected.
China's BCI sector marks its first year of clinical application, with 12 commercial implants approved and partial reimbursement now available in Shanghai.
Synchron has halted clinical trials of its brain implant following performance issues, marking a significant setback for the BCI sector.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →ALS Community Gains a Formal Voice in Brain-Computer Interface Development
People living with ALS will now have direct input into BCI development decisions, marking a shift toward patient-centered neurotech design.
2026-11-19
Science Corporation Closes $400M Round to Push Brain-Computer Interface Technology Into the Clinic
Science Corporation has raised $400M to commercialize its BCI device, marking one of the largest single funding rounds in neurotechnology history.
2026-11-18
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Advance Neuroscience
Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.
2026-11-17
You Cannot Blind a Brain-Computer Interface Trial, and That Changes Everything for Clinical Science
The impossibility of blinding BCI clinical trials poses fundamental methodological challenges that could reshape how the field validates its devices.
2026-11-16
Implanted BCIs Restore Expressive Communication for Paralyzed Clinical Trial Participants
New clinical trial data shows implanted brain-computer interfaces successfully restoring expressive communication in paralyzed patients.
2026-11-15
Synchron Halts BCI Trials After Device Falls Short of Performance Benchmarks
Synchron has suspended its brain-computer interface clinical trials after the implanted device failed to perform as expected.
2026-11-14
The field, by the numbers
800+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
131+
Articles
research & industry
Companies by sector
30
Brain-Computer
16
Cognitive
29
Mental
47
Neuromodulation
41
Neuropharmaceuticals
30
Neurodiagnostics
11
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.